John S. McCain Opioid Addiction Prevention Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 7, 2019)
John S. McCain Opioid Addiction Prevention Act
This bill establishes a new registration requirement for practitioners who are licensed to prescribe controlled substances in schedule II, III, or IV.
Specifically, a practitioner must agree to limit the supply of opioids prescribed for the initial treatment of acute pain, as a condition of obtaining or renewing a registration through the Drug Enforcement Administration.
An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
What just happenedApr 12, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Who’s behind it
- Introduced in HouseMar 7, 2019
- Apr 12, 2019Committee
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Crime and Federal Government Surveillance Subcommittee - Mar 8, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 7, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - Mar 7, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Mar 7, 2019IntroReferralIntro-H
Introduced in House
- Mar 7, 2019IntroReferral1000
Introduced in House